Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures

Mikayla L. Spangler, Beth Bryles Phillips, Mary B. Ross, Kevin G. Moores

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Purpose. The most recent large-scale studies evaluating the effects of calcium supplementation for prevention of osteoporosis-related fractures in postmenopausal women are reviewed. Summary. Osteoporosis is a very common disease associated with significant morbidity and mortality. For many years, use of a calcium supplement (preferably in combination with vitamin D to optimize calcium absorption) has been recommended for postmenopausal women to decrease fracture risk. However, five large-scale, randomized, controlled trials have called into question the benefits of calcium in reducing fracture risk, and four of the studies indicated that calcium users may be at increased risk for renal stones and gastrointestinal problems. However, all five studies had one or more important limitations, including possible selection bias and study participants' relatively high baseline calcium intake and generally low adherence to treatment regimens. Moreover, in some of the studies, vitamin D was not included in the treatment protocol or was not used at levels sufficient to optimize calcium absorption. In three of the five trials, subgroup analysis of the most treatment-adherent participants indicated significant reductions in osteoporotic fracture risk with calcium supplement use. Conclusion. Results of recent clinical trials indicate that calcium supplementation does not significantly reduce fracture risk in postmenopausal women. However, evidence from the same studies suggests that beneficial effects on fracture risk may be seen in women who are adherent to therapy. Postmenopausal women should continue calcium supplementation to reduce osteoporosis risk.

Original languageEnglish
Pages (from-to)309-318
Number of pages10
JournalAmerican Journal of Health-System Pharmacy
Volume68
Issue number4
DOIs
StatePublished - Feb 15 2011

Fingerprint

Osteoporotic Fractures
Calcium
Osteoporosis
Vitamin D
Selection Bias
Clinical Protocols
Therapeutics
Randomized Controlled Trials
Clinical Trials
Morbidity
Kidney

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Health Policy

Cite this

Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures. / Spangler, Mikayla L.; Phillips, Beth Bryles; Ross, Mary B.; Moores, Kevin G.

In: American Journal of Health-System Pharmacy, Vol. 68, No. 4, 15.02.2011, p. 309-318.

Research output: Contribution to journalReview article

Spangler, Mikayla L. ; Phillips, Beth Bryles ; Ross, Mary B. ; Moores, Kevin G. / Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures. In: American Journal of Health-System Pharmacy. 2011 ; Vol. 68, No. 4. pp. 309-318.
@article{a20ff2705c274cfaab55307afe75a6c8,
title = "Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures",
abstract = "Purpose. The most recent large-scale studies evaluating the effects of calcium supplementation for prevention of osteoporosis-related fractures in postmenopausal women are reviewed. Summary. Osteoporosis is a very common disease associated with significant morbidity and mortality. For many years, use of a calcium supplement (preferably in combination with vitamin D to optimize calcium absorption) has been recommended for postmenopausal women to decrease fracture risk. However, five large-scale, randomized, controlled trials have called into question the benefits of calcium in reducing fracture risk, and four of the studies indicated that calcium users may be at increased risk for renal stones and gastrointestinal problems. However, all five studies had one or more important limitations, including possible selection bias and study participants' relatively high baseline calcium intake and generally low adherence to treatment regimens. Moreover, in some of the studies, vitamin D was not included in the treatment protocol or was not used at levels sufficient to optimize calcium absorption. In three of the five trials, subgroup analysis of the most treatment-adherent participants indicated significant reductions in osteoporotic fracture risk with calcium supplement use. Conclusion. Results of recent clinical trials indicate that calcium supplementation does not significantly reduce fracture risk in postmenopausal women. However, evidence from the same studies suggests that beneficial effects on fracture risk may be seen in women who are adherent to therapy. Postmenopausal women should continue calcium supplementation to reduce osteoporosis risk.",
author = "Spangler, {Mikayla L.} and Phillips, {Beth Bryles} and Ross, {Mary B.} and Moores, {Kevin G.}",
year = "2011",
month = "2",
day = "15",
doi = "10.2146/ajhp070175",
language = "English",
volume = "68",
pages = "309--318",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "4",

}

TY - JOUR

T1 - Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures

AU - Spangler, Mikayla L.

AU - Phillips, Beth Bryles

AU - Ross, Mary B.

AU - Moores, Kevin G.

PY - 2011/2/15

Y1 - 2011/2/15

N2 - Purpose. The most recent large-scale studies evaluating the effects of calcium supplementation for prevention of osteoporosis-related fractures in postmenopausal women are reviewed. Summary. Osteoporosis is a very common disease associated with significant morbidity and mortality. For many years, use of a calcium supplement (preferably in combination with vitamin D to optimize calcium absorption) has been recommended for postmenopausal women to decrease fracture risk. However, five large-scale, randomized, controlled trials have called into question the benefits of calcium in reducing fracture risk, and four of the studies indicated that calcium users may be at increased risk for renal stones and gastrointestinal problems. However, all five studies had one or more important limitations, including possible selection bias and study participants' relatively high baseline calcium intake and generally low adherence to treatment regimens. Moreover, in some of the studies, vitamin D was not included in the treatment protocol or was not used at levels sufficient to optimize calcium absorption. In three of the five trials, subgroup analysis of the most treatment-adherent participants indicated significant reductions in osteoporotic fracture risk with calcium supplement use. Conclusion. Results of recent clinical trials indicate that calcium supplementation does not significantly reduce fracture risk in postmenopausal women. However, evidence from the same studies suggests that beneficial effects on fracture risk may be seen in women who are adherent to therapy. Postmenopausal women should continue calcium supplementation to reduce osteoporosis risk.

AB - Purpose. The most recent large-scale studies evaluating the effects of calcium supplementation for prevention of osteoporosis-related fractures in postmenopausal women are reviewed. Summary. Osteoporosis is a very common disease associated with significant morbidity and mortality. For many years, use of a calcium supplement (preferably in combination with vitamin D to optimize calcium absorption) has been recommended for postmenopausal women to decrease fracture risk. However, five large-scale, randomized, controlled trials have called into question the benefits of calcium in reducing fracture risk, and four of the studies indicated that calcium users may be at increased risk for renal stones and gastrointestinal problems. However, all five studies had one or more important limitations, including possible selection bias and study participants' relatively high baseline calcium intake and generally low adherence to treatment regimens. Moreover, in some of the studies, vitamin D was not included in the treatment protocol or was not used at levels sufficient to optimize calcium absorption. In three of the five trials, subgroup analysis of the most treatment-adherent participants indicated significant reductions in osteoporotic fracture risk with calcium supplement use. Conclusion. Results of recent clinical trials indicate that calcium supplementation does not significantly reduce fracture risk in postmenopausal women. However, evidence from the same studies suggests that beneficial effects on fracture risk may be seen in women who are adherent to therapy. Postmenopausal women should continue calcium supplementation to reduce osteoporosis risk.

UR - http://www.scopus.com/inward/record.url?scp=79956011544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956011544&partnerID=8YFLogxK

U2 - 10.2146/ajhp070175

DO - 10.2146/ajhp070175

M3 - Review article

VL - 68

SP - 309

EP - 318

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 4

ER -